Blockade of Glial Connexin 43 Hemichannels Reduces Food Intake.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
31 10 2020
Historique:
received: 01 10 2020
revised: 20 10 2020
accepted: 26 10 2020
entrez: 4 11 2020
pubmed: 5 11 2020
medline: 22 6 2021
Statut: epublish

Résumé

The metabolic syndrome, which comprises obesity and diabetes, is a major public health problem and the awareness of energy homeostasis control remains an important worldwide issue. The energy balance is finely regulated by the central nervous system (CNS), notably through neuronal networks, located in the hypothalamus and the dorsal vagal complex (DVC), which integrate nutritional, humoral and nervous information from the periphery. The glial cells' contribution to these processes emerged few year ago. However, its underlying mechanism remains unclear. Glial connexin 43 hemichannels (Cx43 HCs) enable direct exchange with the extracellular space and can regulate neuronal network activity. In the present study, we sought to determine the possible involvement of glial Cx43 HCs in energy balance regulation. We here show that Cx43 is strongly expressed in the hypothalamus and DVC and is associated with glial cells. Remarkably, we observed a close apposition of Cx43 with synaptic elements in both the hypothalamus and DVC. Moreover, the expression of hypothalamic Cx43 mRNA and protein is modulated in response to fasting and diet-induced obesity. Functionally, we found that Cx43 HCs are largely open in the arcuate nucleus (ARC) from acute mice hypothalamic slices under basal condition, and significantly inhibited by TAT-GAP19, a mimetic peptide that specifically blocks Cx43 HCs activity. Moreover, intracerebroventricular (i.c.v.) TAT-GAP19 injection strongly decreased food intake, without further alteration of glycaemia, energy expenditures or locomotor activity. Using the immediate early gene c-Fos expression, we found that i.c.v. TAT-GAP19 injection induced neuronal activation in hypothalamic and brainstem nuclei dedicated to food intake regulation. Altogether, these results suggest a tonic delivery of orexigenic molecules associated with glial Cx43 HCs activity and a possible modulation of this tonus during fasting and obesity.

Identifiants

pubmed: 33142723
pii: cells9112387
doi: 10.3390/cells9112387
pmc: PMC7693394
pii:
doi:

Substances chimiques

Connexin 43 0
GJA1 protein, mouse 0
Peptide Fragments 0
Proto-Oncogene Proteins c-fos 0
TAT-Gap19 peptide 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Anat Rec. 1991 Dec;231(4):482-97
pubmed: 1793176
J Cereb Blood Flow Metab. 2014 Feb;34(2):339-46
pubmed: 24301293
Glia. 2018 Aug;66(8):1788-1804
pubmed: 29683209
Biochim Biophys Acta. 2005 Dec 20;1719(1-2):6-23
pubmed: 16359940
J Neurosci. 2017 Sep 13;37(37):9064-9075
pubmed: 28821660
J Comp Neurol. 1996 Dec 09;376(2):326-42
pubmed: 8951647
Adv Exp Med Biol. 2020;1265:167-185
pubmed: 32761576
J Neurosci. 2014 Aug 20;34(34):11228-32
pubmed: 25143604
Front Pharmacol. 2013 Jul 17;4:88
pubmed: 23882216
Front Endocrinol (Lausanne). 2015 Mar 26;6:42
pubmed: 25859240
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11388-93
pubmed: 13130072
Biochim Biophys Acta. 2004 Mar 23;1662(1-2):113-37
pubmed: 15033583
Brain Res. 2017 Oct 15;1673:64-71
pubmed: 28803831
Philos Trans R Soc Lond B Biol Sci. 2014 Oct 19;369(1654):20130592
pubmed: 25225086
Obesity (Silver Spring). 2014 Dec;22(12):2552-62
pubmed: 25236366
Brain Behav Immun. 2014 Mar;37:54-72
pubmed: 24355099
Front Cell Neurosci. 2018 Nov 26;12:406
pubmed: 30534054
Glia. 2020 Jun;68(6):1241-1254
pubmed: 31880353
Front Synaptic Neurosci. 2016 Jan 12;7:19
pubmed: 26793095
Trends Mol Med. 2007 Oct;13(10):443-8
pubmed: 17913584
Adv Exp Med Biol. 2018;1071:61-68
pubmed: 30357734
Front Cell Neurosci. 2014 Oct 21;8:306
pubmed: 25374505
Front Neurosci. 2017 May 30;11:308
pubmed: 28611581
J Comp Neurol. 2007 Mar 20;501(3):353-68
pubmed: 17245710
Nat Neurosci. 2019 Jan;22(1):7-14
pubmed: 30531847
J Physiol. 2010 Oct 15;588(Pt 20):3901-20
pubmed: 20736421
FASEB J. 2012 Sep;26(9):3649-57
pubmed: 22665389
J Physiol Paris. 2012 Jan;106(1-2):34-9
pubmed: 21979115
Nature. 1996 Jul 18;382(6588):250-2
pubmed: 8717038
BMC Neurosci. 2010 Aug 27;11:108
pubmed: 20796318
Philos Trans R Soc Lond B Biol Sci. 2014 Oct 19;369(1654):20130596
pubmed: 25225090
Mol Membr Biol. 2002 Apr-Jun;19(2):121-36
pubmed: 12126230
Neuroscience. 2019 Jan 1;396:73-78
pubmed: 30458223
Physiol Behav. 2011 Jul 25;104(1):40-6
pubmed: 21550353
Neuroscience. 2015 Apr 16;291:241-9
pubmed: 25681519
Neuroscience. 2015 Feb 12;286:45-59
pubmed: 25475761
Neuroscience. 2010 Nov 24;171(1):62-78
pubmed: 20736052
Front Endocrinol (Lausanne). 2019 Apr 16;10:244
pubmed: 31040827
J Neurosci Methods. 1989 Sep;29(3):261-5
pubmed: 2507830
Acta Physiol (Oxf). 2019 Jan;225(1):e13108
pubmed: 29858558
Brain Res. 2010 Sep 2;1350:35-42
pubmed: 20451504
BMC Cell Biol. 2016 May 24;17 Suppl 1:11
pubmed: 27229925
Eur J Neurosci. 2006 Oct;24(7):2049-56
pubmed: 17067301
Anat Rec. 1976 Jun;185(2):247-51
pubmed: 1275310
Toxicol Sci. 2011 Nov;124(1):179-91
pubmed: 21873375
Sensors (Basel). 2010;10(10):9002-25
pubmed: 22022208
J Neuroendocrinol. 2009 Jan;21(1):57-67
pubmed: 19094094
J Neuroendocrinol. 2019 May;31(5):e12726
pubmed: 31050045
J Microsc. 1987 Sep;147(Pt 3):229-63
pubmed: 3430576
Mol Neurobiol. 2020 Aug;57(8):3307-3333
pubmed: 32519243
Endocr Rev. 2018 Jun 1;39(3):333-368
pubmed: 29351662
Front Mol Neurosci. 2018 Dec 04;11:435
pubmed: 30564096

Auteurs

Florent Guillebaud (F)

Cognitive Neuroscience Laboratory, Aix-Marseille University, UMR 7291 CNRS, 13003 Marseille, France.

Manon Barbot (M)

Cognitive Neuroscience Laboratory, Aix-Marseille University, UMR 7291 CNRS, 13003 Marseille, France.

Rym Barbouche (R)

Cognitive Neuroscience Laboratory, Aix-Marseille University, UMR 7291 CNRS, 13003 Marseille, France.

Jean-Michel Brézun (JM)

Institute of Movement Sciences, Aix-Marseille University, UMR 7287 CNRS, 13009 Marseille, France.

Kevin Poirot (K)

Cognitive Neuroscience Laboratory, Aix-Marseille University, UMR 7291 CNRS, 13003 Marseille, France.

Flora Vasile (F)

Neuroglial Interactions in Cerebral Physiopathology, Collège de France, CIRB CNRS 7241, Inserm U1050, Labex Memolife, PSL Research University, 75231 Paris, France.

Bruno Lebrun (B)

Cognitive Neuroscience Laboratory, Aix-Marseille University, UMR 7291 CNRS, 13003 Marseille, France.

Nathalie Rouach (N)

Neuroglial Interactions in Cerebral Physiopathology, Collège de France, CIRB CNRS 7241, Inserm U1050, Labex Memolife, PSL Research University, 75231 Paris, France.

Michel Dallaporta (M)

Cognitive Neuroscience Laboratory, Aix-Marseille University, UMR 7291 CNRS, 13003 Marseille, France.

Stéphanie Gaige (S)

Cognitive Neuroscience Laboratory, Aix-Marseille University, UMR 7291 CNRS, 13003 Marseille, France.

Jean-Denis Troadec (JD)

Cognitive Neuroscience Laboratory, Aix-Marseille University, UMR 7291 CNRS, 13003 Marseille, France.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH